CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8
Clinical trials for CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Flu vaccine injected into tumors shows promise against melanoma
Disease control Recruiting nowThis early-stage trial is testing whether injecting a flu vaccine directly into melanoma tumors can help shrink them. The study includes adults with stage I to IV melanoma who have at least one tumor that can be injected. The main goals are to find the safest dose and to see what…
Matched conditions: CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: Carlo Contreras • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Can your social life help you beat Cancer's aftermath? new study investigates
Knowledge-focused Recruiting nowThis study looks at how personal relationships and physical activity influence the quality of life of young adults (ages 18-39) who have been diagnosed with cancer. Researchers will track 250 participants over time to see how social connections and exercise habits change and affe…
Matched conditions: CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Could a poop transplant fix cancer treatment side effects?
Knowledge-focused Recruiting nowThis study looks at how the bacteria in your gut might cause stomach issues like diarrhea and colitis when you take certain cancer drugs called immune checkpoint inhibitors. Researchers will collect stool, blood, and tissue samples from 800 people with melanoma, lung cancer, or g…
Matched conditions: CLINICAL STAGE IIA CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC